Form 4: Cencora Executive Gina Clark Executes Stock Options and Sells Shares
SEC Form 4 Filing
Executive Vice President Gina Clark exercised stock options and sold shares of Cencora, Inc. on May 29, 2024, according to a recent SEC Form 4 filing.
Summary
- Gina Clark, an Executive Vice President at Cencora, Inc., reported transactions involving the company's common stock.
- On March 18, 2024, Clark sold 9,644 shares of common stock at a price of $238.12 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan.
- On May 29, 2024, Clark exercised options to acquire 27,093 shares at $86.09 and sold the same amount of shares at a weighted average price of $216.07, with prices ranging from $216.00 to $216.14.
- Following these transactions, Clark directly owns 15,158 shares of Cencora common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Executive stock transactions are a normal part of corporate governance. Monitoring these transactions can provide insights into an executive's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are often used to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The use of Rule 10b5-1 trading plans is a common practice among corporate executives to manage their stock sales in a compliant manner.
- Comparing the volume and frequency of insider transactions at Cencora to those of its peers, such as McKesson and Cardinal Health, can provide a broader context for assessing the significance of these transactions.
Stakeholder Impact
- Shareholders may be interested in these transactions as they provide insight into executive compensation and potential views on the company's stock value.
- The transactions themselves are unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/14/2023 | Effective date of the Rule 10b5-1 trading plan. |
| 03/18/2024 | Sale of 9,644 shares of common stock at $238.12 per share. |
| 05/29/2024 | Exercise of stock options for 27,093 shares at $86.09 and sale of 27,093 shares at a weighted average price of $216.07. |
| 05/31/2024 | Date of the SEC Form 4 filing. |
| 11/13/2026 | Expiration date of the Non-qualified Stock Option (Right to Buy). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.